Zobrazeno 1 - 10
of 59
pro vyhledávání: '"H Tekatli"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N van Voort van der Zyp, Mischa S. Hoogeman, Joost J. Nuyttens, H Tekatli, E. Oomen-de Hoop, P. van de Vaart, Suresh Senan, M. Duijm
Publikováno v:
Duijm, M, Oomen-de Hoop, E, van Voort van der Zyp, N, van de Vaart, P, Tekatli, H, Hoogeman, M, Senan, S & Nuyttens, J 2021, ' The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma ', Radiotherapy and Oncology, vol. 156, pp. 223-230 . https://doi.org/10.1016/j.radonc.2020.12.038
Radiotherapy and Oncology, 156, 223-230. Elsevier Ireland Ltd
Radiotherapy and Oncology, 156, 223-230. Elsevier Ireland Ltd
Background and purpose Current nomograms predicting survival prognosis after stereotactic body radiation therapy (SBRT) in non-small cell lung cancer (NSCLC) are based on peripherally located tumors. However, patients with a central lung tumor tend t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74e3608e9d31c4e180b5be834e2dbdb5
https://research.vumc.nl/en/publications/50a51e30-b7cf-4e1e-97de-cab5ba2ca9b8
https://research.vumc.nl/en/publications/50a51e30-b7cf-4e1e-97de-cab5ba2ca9b8
Autor:
J.R. van Sornsen de Koste, Suresh Senan, Berend J. Slotman, H. Tekatli, Femke O.B. Spoelstra, Miguel A. Palacios
Publikováno v:
Tekatli, H, Spoelstra, F O B, Palacios, M, van Sornsen de Koste, J, Slotman, B J & Senan, S 2018, ' Stereotactic ablative radiotherapy (SABR) for early-stage central lung tumors : New insights and approaches ', Lung Cancer, vol. 123, pp. 142-148 . https://doi.org/10.1016/j.lungcan.2018.07.002
The use of stereotactic ablative radiotherapy (SABR) for central lung tumors is increasing. Centrally located lung tumors can be subdivided into two categories, namely the ‘moderately central’ tumors where the planning target volume is located wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88342fd1249dba28121e635985b31b07
https://doi.org/10.1016/j.lungcan.2018.07.002
https://doi.org/10.1016/j.lungcan.2018.07.002
Autor:
Joost J. Nuyttens, N. van der Voort van Zyp, Suresh Senan, P. van de Vaart, M. Duijm, H. Tekatli, Mischa S. Hoogeman, E. Oomen-de Hoop
Publikováno v:
Radiotherapy and Oncology. 152:S408-S409
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82cfa577df564d56113533402a77ce6f
https://doi.org/10.1016/s0167-8140(21)00743-x
https://doi.org/10.1016/s0167-8140(21)00743-x
Autor:
Saar van ’t Hof, Max Dahele, Jos W. R. Twisk, Alexander R. Delaney, Ben J. Slotman, H. Tekatli, Wilko F.A.R. Verbakel, Suresh Senan
Publikováno v:
International journal of radiation oncology, biology, physics, 103(1), 259-267. Elsevier Inc.
Hof, S V T, Delaney, A R, Tekatli, H, Twisk, J, Slotman, B J, Senan, S, Dahele, M & Verbakel, W F 2019, ' Knowledge-Based Planning for Identifying High-Risk Stereotactic Ablative Radiation Therapy Treatment Plans for Lung Tumors Larger Than 5 cm ', International journal of radiation oncology, biology, physics, vol. 103, no. 1, pp. 259-267 . https://doi.org/10.1016/j.ijrobp.2018.08.013
Hof, S V T, Delaney, A R, Tekatli, H, Twisk, J, Slotman, B J, Senan, S, Dahele, M & Verbakel, W F 2019, ' Knowledge-Based Planning for Identifying High-Risk Stereotactic Ablative Radiation Therapy Treatment Plans for Lung Tumors Larger Than 5 cm ', International journal of radiation oncology, biology, physics, vol. 103, no. 1, pp. 259-267 . https://doi.org/10.1016/j.ijrobp.2018.08.013
Purpose Stereotactic ablative body radiation therapy (SABR) for lung tumors ≥5 cm can be associated with more toxicity than that for smaller tumors. We investigated the relationship between dosimetry and toxicity and used a knowledge-based planning
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c5aed7e45dc87258f44a01ff4d70f806
https://research.vumc.nl/en/publications/b9956682-ba26-4f76-aac2-8803c7fc677c
https://research.vumc.nl/en/publications/b9956682-ba26-4f76-aac2-8803c7fc677c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
M. Duijm, Wilko F.A.R. Verbakel, Joost J. Nuyttens, Suresh Senan, E. Oomen-de Hoop, H. Tekatli, Berend J. Slotman, W. Schillemans
Publikováno v:
Duijm, M, Tekatli, H, Oomen-de Hoop, E, Verbakel, W, Schillemans, W, Slotman, B J, Senan, S & Nuyttens, J J 2018, ' Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors : Normal tissue complication probability modeling ', Radiotherapy and Oncology, vol. 127, no. 2, pp. 233-238 . https://doi.org/10.1016/j.radonc.2018.02.004
Radiotherapy and Oncology, 127(2), 233-238. Elsevier Ireland Ltd
Radiotherapy and Oncology, 127(2), 233-238. Elsevier Ireland Ltd
PURPOSE: To correlate esophagus toxicity and dose-volume histogram (DVH) parameters in order to assess risks, and derive a Normal Tissue Complication Probability (NTCP) model.METHODS AND MATERIALS: Patients with a central lung tumor from 2 centers, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b588d4e824b6ab513837cf67a675d1c
https://research.vumc.nl/en/publications/19691619-853e-49fa-a07c-826db35ef41f
https://research.vumc.nl/en/publications/19691619-853e-49fa-a07c-826db35ef41f
Autor:
Huiberdina L. Koek, F.A.M. Klijn, Arjen J. C. Slooter, D. van Dijk, A.W. van der Kooi, Irene J. Zaal, H. Tekatli
Publikováno v:
Journal of Critical Care, 30(2), 375. Elsevier BV
Purpose The purpose of this study is to develop a reliable tool for daily mental status classification in intensive care unit (ICU) patients for research purposes. Secondly, to identify patients with single, 1-day episodes of delirium and to compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b71641bb400730c9f3e3ddc2b269d28
https://doi.org/10.1016/j.jcrc.2014.10.031
https://doi.org/10.1016/j.jcrc.2014.10.031
Autor:
Suresh Senan, Esther J. Nossent, Max Dahele, Saar van ’t Hof, Ben J. Slotman, H. Tekatli, Wilko F.A.R. Verbakel
Publikováno v:
Journal of Thoracic Oncology, 12(6), 974-982. International Association for the Study of Lung Cancer
Tekatli, H, van ’t Hof, S, Nossent, E J, Dahele, M, Verbakel, W F A R, Slotman, B J & Senan, S 2017, ' Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm ', Journal of Thoracic Oncology, vol. 12, no. 6, pp. 974-982 . https://doi.org/10.1016/j.jtho.2017.02.021
Tekatli, H, van ’t Hof, S, Nossent, E J, Dahele, M, Verbakel, W F A R, Slotman, B J & Senan, S 2017, ' Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm ', Journal of Thoracic Oncology, vol. 12, no. 6, pp. 974-982 . https://doi.org/10.1016/j.jtho.2017.02.021
Introduction Stereotactic ablative radiotherapy (SABR) is currently not the guideline-recommended treatment for lung tumors measuring more than 5 cm. However, improvements in radiotherapy techniques have led to increasing use of SABR for larger tumor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ecaed678484415408af0394ccd10683e
https://research.vumc.nl/en/publications/6dfd0dda-b8ff-41e0-92c4-ca1de1494e59
https://research.vumc.nl/en/publications/6dfd0dda-b8ff-41e0-92c4-ca1de1494e59